Despite higher endogenous E2 concentration also being a known risk factor for breast cancer (Key et al. 2002), candidate SNP studies of CYP19A1 have not reported an association with breast cancer (Haiman et al. 2007). This evidence concerns the gene CYP19A1 and breast cancer.